Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for IART

Stock Name	Integra LifeSciences Holdings
Ticker	IART(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US4579852082
LEI	WB7IJCYY8YFTENS4O147

Show aggregate IART holdings

News associated with IART

Integra LifeSciences Holdings Corporation (NASDAQ:IART) Receives $18.63 Consensus Target Price from Analysts: Shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART – Get Free Report) have received an average recommendation of “Reduce” from the nine ratings firms that are covering the firm, Marketbeat Ratings reports. Four research analysts have rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating […] - 2025-08-06 02:14:54
Integra LifeSciences (NASDAQ:IART) Shares Up 8.8% on Better-Than-Expected Earnings: Shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART – Get Free Report) traded up 8.8% during trading on Thursday following a better than expected earnings announcement. The company traded as high as $14.07 and last traded at $13.46. 362,656 shares were traded during trading, a decline of 62% from the average session volume of 964,277 shares. […] - 2025-08-01 03:10:52
Victory Capital Management Inc. Acquires 135,308 Shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART): Victory Capital Management Inc. raised its holdings in Integra LifeSciences Holdings Corporation (NASDAQ:IART – Free Report) by 1,067.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 147,982 shares of the life sciences company’s stock after buying an additional 135,308 shares during the quarter. […] - 2025-07-28 05:16:52
Bank of New York Mellon Corp Sells 30,447 Shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART): Bank of New York Mellon Corp decreased its stake in Integra LifeSciences Holdings Corporation (NASDAQ:IART – Free Report) by 6.5% in the 1st quarter, Holdings Channel.com reports. The fund owned 437,515 shares of the life sciences company’s stock after selling 30,447 shares during the quarter. Bank of New York Mellon Corp’s holdings in Integra LifeSciences […] - 2025-07-22 06:22:52
11,425 Shares in Integra LifeSciences Holdings Corporation (NASDAQ:IART) Acquired by Wealth Enhancement Advisory Services LLC: Wealth Enhancement Advisory Services LLC acquired a new position in Integra LifeSciences Holdings Corporation (NASDAQ:IART – Free Report) in the 1st quarter, Holdings Channel reports. The firm acquired 11,425 shares of the life sciences company’s stock, valued at approximately $251,000. Other hedge funds also recently added to or reduced their stakes in the company. Assenagon […] - 2025-07-10 04:14:55
Integra LifeSciences Holdings Co. (NASDAQ:IART) Receives $18.63 Consensus PT from Analysts: Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Free Report) have been assigned a consensus rating of “Reduce” from the nine brokerages that are currently covering the company, Marketbeat Ratings reports. Four investment analysts have rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy […] - 2025-06-17 02:49:03
Analyzing Integra LifeSciences (NASDAQ:IART) and Arch Therapeutics (OTCMKTS:ARTH): Arch Therapeutics (OTCMKTS:ARTH – Get Free Report) and Integra LifeSciences (NASDAQ:IART – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations. Volatility and Risk Arch Therapeutics has a […] - 2025-06-16 02:40:44
Integra LifeSciences Holdings Co. (NASDAQ:IART) Shares Sold by Squarepoint Ops LLC: Squarepoint Ops LLC decreased its position in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 71.8% during the fourth quarter, Holdings Channel.com reports. The firm owned 25,285 shares of the life sciences company’s stock after selling 64,458 shares during the period. Squarepoint Ops LLC’s holdings in Integra LifeSciences were worth $573,000 as […] - 2025-06-04 05:48:48
75,900 Shares in Integra LifeSciences Holdings Co. (NASDAQ:IART) Bought by Universal Beteiligungs und Servicegesellschaft mbH: Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) during the 4th quarter, Holdings Channel.com reports. The firm purchased 75,900 shares of the life sciences company’s stock, valued at approximately $1,721,000. Other hedge funds and other institutional investors have also recently bought and sold […] - 2025-06-03 05:34:56
BNP Paribas Financial Markets Has $333,000 Position in Integra LifeSciences Holdings Co. (NASDAQ:IART): BNP Paribas Financial Markets cut its stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 86.9% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 14,690 shares of the life sciences company’s stock after selling 97,085 shares during the period. BNP Paribas Financial […] - 2025-05-27 06:12:44
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Buys 1,437 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART): MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 3.9% in the 4th quarter, Holdings Channel reports. The institutional investor owned 38,466 shares of the life sciences company’s stock after buying an additional 1,437 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS […] - 2025-05-27 04:47:03
Financial Review: Integra LifeSciences (NASDAQ:IART) and Vivos (OTCMKTS:RDGL): Integra LifeSciences (NASDAQ:IART – Get Free Report) and Vivos (OTCMKTS:RDGL – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership and earnings. Profitability This table compares Integra LifeSciences and Vivos’ […] - 2025-05-26 02:20:55
Brokerages Set Integra LifeSciences Holdings Co. (NASDAQ:IART) Price Target at $18.63: Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Free Report) have been given an average recommendation of “Reduce” by the nine analysts that are currently covering the company, MarketBeat Ratings reports. Four research analysts have rated the stock with a sell recommendation, three have assigned a hold recommendation and two have issued a buy […] - 2025-05-23 02:48:54
Integra LifeSciences (NASDAQ:IART) Hits New 12-Month Low Following Weak Earnings: Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Free Report) hit a new 52-week low during mid-day trading on Tuesday after the company announced weaker than expected quarterly earnings. The company traded as low as $11.60 and last traded at $13.28, with a volume of 7492449 shares trading hands. The stock had previously closed […] - 2025-05-07 03:10:42
Head to Head Review: Integra LifeSciences (NASDAQ:IART) & Venus Concept (NASDAQ:VERO): Venus Concept (NASDAQ:VERO – Get Free Report) and Integra LifeSciences (NASDAQ:IART – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, earnings, valuation, profitability and analyst recommendations. Analyst Recommendations This is a breakdown of […] - 2025-05-06 02:46:55
Integra LifeSciences (NASDAQ:IART) Shares Gap Down Following Weak Earnings: Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Free Report) gapped down before the market opened on Monday following a dissappointing earnings announcement. The stock had previously closed at $16.85, but opened at $14.73. Integra LifeSciences shares last traded at $11.88, with a volume of 1,189,112 shares traded. The life sciences company reported $0.41 […] - 2025-05-06 02:10:50
Integra LifeSciences Holdings Co. (NASDAQ:IART) Receives $22.71 Consensus PT from Analysts: Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Free Report) has earned an average recommendation of “Reduce” from the nine ratings firms that are covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the […] - 2025-04-28 02:24:43
Integra LifeSciences Holdings Co. (NASDAQ:IART) Shares Purchased by Sterling Capital Management LLC: Sterling Capital Management LLC boosted its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 821.7% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 2,166 shares of the life sciences company’s stock after purchasing an additional 1,931 shares during the period. Sterling Capital Management LLC’s […] - 2025-04-24 05:46:54
Legal & General Group Plc Has $4.91 Million Stock Position in Integra LifeSciences Holdings Co. (NASDAQ:IART): Legal & General Group Plc lessened its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 6.9% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 216,507 shares of the life sciences company’s stock after selling 16,109 shares during the quarter. Legal & […] - 2025-04-22 04:44:49
Sei Investments Co. Decreases Stock Position in Integra LifeSciences Holdings Co. (NASDAQ:IART): Sei Investments Co. trimmed its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 19.0% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 18,953 shares of the life sciences company’s stock after selling 4,448 shares during the period. Sei Investments Co.’s holdings in Integra LifeSciences were worth $430,000 at the […] - 2025-04-10 04:24:49
Integra LifeSciences Holdings Co. (NASDAQ:IART) Shares Sold by Vanguard Group Inc.: Vanguard Group Inc. trimmed its holdings in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 2.1% in the fourth quarter, HoldingsChannel reports. The firm owned 7,580,967 shares of the life sciences company’s stock after selling 162,961 shares during the period. Vanguard Group Inc. owned approximately 0.10% of Integra LifeSciences worth $171,936,000 at […] - 2025-04-07 04:41:00
Integra LifeSciences (NASDAQ:IART) Raised to Buy at Argus: Integra LifeSciences (NASDAQ:IART – Get Free Report) was upgraded by equities research analysts at Argus from a “hold” rating to a “buy” rating in a report released on Monday, MarketBeat Ratings reports. Separately, Morgan Stanley assumed coverage on shares of Integra LifeSciences in a research report on Monday, December 2nd. They issued an “underweight” rating […] - 2025-04-02 03:12:48
Quantbot Technologies LP Has $179,000 Stock Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART): Quantbot Technologies LP lowered its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 89.1% during the fourth quarter, HoldingsChannel.com reports. The firm owned 7,881 shares of the life sciences company’s stock after selling 64,470 shares during the period. Quantbot Technologies LP’s holdings in Integra LifeSciences were worth $179,000 at the end of […] - 2025-03-31 04:39:00
Intech Investment Management LLC Acquires 11,174 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART): Intech Investment Management LLC raised its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 86.4% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 24,113 shares of the life sciences company’s stock after acquiring an additional 11,174 shares during the period. Intech Investment Management LLC’s holdings in Integra LifeSciences were worth […] - 2025-03-25 07:08:55
PNC Financial Services Group Inc. Grows Stake in Integra LifeSciences Holdings Co. (NASDAQ:IART): PNC Financial Services Group Inc. lifted its stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 33.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 19,755 shares of the life sciences company’s stock after purchasing an additional […] - 2025-03-20 05:57:04
Integra LifeSciences Holdings Co. (NASDAQ:IART) Holdings Lowered by Bank of New York Mellon Corp: Bank of New York Mellon Corp cut its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 3.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 467,962 shares of the life sciences company’s stock after selling 15,830 shares […] - 2025-03-14 05:05:06
Amalgamated Bank Sells 478 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART): Amalgamated Bank reduced its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 2.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 19,394 shares of the life sciences company’s stock after selling 478 shares during the quarter. Amalgamated Bank’s holdings […] - 2025-03-05 08:26:53
Yousif Capital Management LLC Sells 906 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART): Yousif Capital Management LLC decreased its position in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 3.4% in the 4th quarter, HoldingsChannel reports. The firm owned 25,762 shares of the life sciences company’s stock after selling 906 shares during the quarter. Yousif Capital Management LLC’s holdings in Integra LifeSciences were worth $584,000 […] - 2025-02-17 06:42:58

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc IART holdings

Date	Number of IART Shares Held	Base Market Value of IART Shares	Local Market Value of IART Shares	Change in IART Shares Held	Change in IART Base Value	Current Price per IART Share Held	Previous Price per IART Share Held
2025-12-11 (Thursday)	32,792	USD 460,728	USD 460,728	0	USD 12,789	USD 14.05	USD 13.66
2025-12-10 (Wednesday)	32,792	USD 447,939	USD 447,939	0	USD 15,740	USD 13.66	USD 13.18
2025-12-09 (Tuesday)	32,792	USD 432,199	USD 432,199	0	USD 5,247	USD 13.18	USD 13.02
2025-12-08 (Monday)	32,792	USD 426,952	USD 426,952	0	USD -7,214	USD 13.02	USD 13.24
2025-12-05 (Friday)	32,792	USD 434,166	USD 434,166	0	USD -10,821	USD 13.24	USD 13.57
2025-12-04 (Thursday)	32,792	USD 444,987	USD 444,987	0	USD 2,623	USD 13.57	USD 13.49
2025-12-03 (Wednesday)	32,792	USD 442,364	USD 442,364	-575	USD 3,254	USD 13.49	USD 13.16
2025-12-02 (Tuesday)	33,367	USD 439,110	USD 439,110	230	USD 6,341	USD 13.16	USD 13.06
2025-12-01 (Monday)	33,137	USD 432,769	USD 432,769	0	USD -1,988	USD 13.06	USD 13.12
2025-11-28 (Friday)	33,137	USD 434,757	USD 434,757	0	USD 0	USD 13.12	USD 13.12
2025-11-27 (Thursday)	33,137	USD 434,757	USD 434,757	0	USD 0	USD 13.12	USD 13.12
2025-11-26 (Wednesday)	33,137	USD 434,757	USD 434,757	0	USD -4,308	USD 13.12	USD 13.25
2025-11-25 (Tuesday)	33,137	USD 439,065	USD 439,065	-345	USD 21,210	USD 13.25	USD 12.48

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of IART by Blackrock for IE00B3VWM098

Show aggregate share trades of IART

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-03 SELL -575 13.650 13.270 13.308 USD -7,652 17.49 Profit of 2,405 on sale
2025-12-02 BUY 230 13.340 12.860 12.908 USD 2,969 17.51
2025-11-25 SELL -345 13.295 12.485 12.566 USD -4,335 17.62 Profit of 1,743 on sale
2025-11-24 SELL -345 12.600 11.950 12.015 USD -4,145 17.64 Profit of 1,941 on sale
2025-11-17 SELL -1,265 11.905 11.510 11.550 USD -14,610 17.80 Profit of 7,902 on sale
2025-11-12 SELL -115 12.730 12.070 12.136 USD -1,396 17.89 Profit of 661 on sale
2025-11-06 SELL -115 11.330 11.010 11.042 USD -1,270 18.01 Profit of 801 on sale
2025-11-05 SELL -1,150 11.570 10.870 10.940 USD -12,581 18.04 Profit of 8,168 on sale
2025-11-04 SELL -230 11.600 11.220 11.258 USD -2,589 18.08 Profit of 1,569 on sale
2025-11-03 SELL -230 11.845 11.080 11.156 USD -2,566 18.11 Profit of 1,600 on sale
2025-10-28 BUY 345 15.560 15.850 15.821 USD 5,458 18.21
2025-10-24 SELL -115 16.120 16.270 16.255 USD -1,869 18.23 Profit of 227 on sale
2025-10-15 BUY 690 14.230 14.910 14.842 USD 10,241 18.35
2025-10-02 BUY 115 13.970 14.730 14.654 USD 1,685 18.39
2025-09-30 BUY 230 14.330 14.420 14.411 USD 3,315 18.44
2025-09-11 BUY 460 15.470 15.730 15.704 USD 7,224 18.57
2025-08-21 SELL -163 13.680 14.240 14.184 USD -2,312 18.60 Profit of 720 on sale
2025-07-31 BUY 489 13.140 14.070 13.977 USD 6,835 18.66
2025-06-30 SELL -326 12.270 12.500 12.477 USD -4,068 19.45 Profit of 2,273 on sale
2025-06-25 SELL -163 11.870 12.010 11.996 USD -1,955 19.60 Profit of 1,240 on sale
2025-06-20 SELL -326 11.600 12.140 12.086 USD -3,940 19.77 Profit of 2,505 on sale
2025-05-23 BUY 163 12.300 12.500 12.480 USD 2,034 20.94
2025-05-19 SELL -163 13.550 13.620 13.613 USD -2,219 21.21 Profit of 1,239 on sale
2025-05-15 SELL -489 13.010 13.090 13.082 USD -6,397 21.35 Profit of 4,044 on sale
2025-05-12 SELL -163 13.670 13.930 13.904 USD -2,266 21.57 Profit of 1,249 on sale
2025-05-09 SELL -163 12.250 12.890 12.826 USD -2,091 21.65 Profit of 1,439 on sale
2025-04-30 SELL -163 16.390 17.200 17.119 USD -2,790 22.14 Profit of 819 on sale
2025-04-24 SELL -326 16.700 16.920 16.898 USD -5,509 22.35 Profit of 1,778 on sale
2025-04-17 SELL -163 15.830 15.960 15.947 USD -2,599 22.70 Profit of 1,101 on sale
2025-04-15 SELL -489 16.080 16.910 16.827 USD -8,228 22.85 Profit of 2,946 on sale
2025-04-14 SELL -489 16.730 17.290 17.234 USD -8,427 22.92 Profit of 2,780 on sale
2025-04-09 SELL -652 19.190 19.250 19.244 USD -12,547 23.09 Profit of 2,508 on sale
2025-04-07 SELL -1,141 19.580 20.410 20.327 USD -23,193 23.19 Profit of 3,267 on sale
2025-04-04 SELL -1,630 19.570 19.860 19.831 USD -32,325 23.23 Profit of 5,546 on sale
2025-03-31 BUY 163 21.990 22.270 22.242 USD 3,625 23.29
2025-03-19 SELL -326 22.820 22.950 22.937 USD -7,477 23.39 Profit of 149 on sale
2025-03-14 SELL -978 22.350 22.890 22.836 USD -22,334 23.42 Profit of 573 on sale
2025-03-13 SELL -328 22.270 22.730 22.684 USD -7,440 23.44 Profit of 248 on sale
2025-03-12 SELL -5,576 22.240 24.370 24.157 USD -134,699 23.46 Loss of -3,907 on sale
2025-03-07 SELL -328 23.000 23.190 23.171 USD -7,600 23.47 Profit of 98 on sale
2025-03-06 SELL -492 22.030 22.090 22.084 USD -10,865 23.49 Profit of 692 on sale
2025-03-03 SELL -164 22.480 23.560 23.452 USD -3,846 23.56 Profit of 17 on sale
2025-02-28 SELL -984 23.210 23.250 23.246 USD -22,874 23.56 Profit of 313 on sale
2025-02-26 SELL -164 23.600 24.860 24.734 USD -4,056 23.57 Loss of -191 on sale
2025-02-25 SELL -492 24.720 25.450 25.377 USD -12,485 23.55 Loss of -898 on sale
2025-02-18 BUY 820 23.320 24.200 24.112 USD 19,772 23.68
2025-02-13 BUY 164 24.260 24.340 24.332 USD 3,990 23.64
2025-02-12 BUY 164 24.080 25.500 25.358 USD 4,159 23.64
2025-02-11 BUY 492 25.680 25.950 25.923 USD 12,754 23.59
2025-02-06 BUY 1,476 26.020 26.980 26.884 USD 39,681 23.46
2025-01-27 BUY 164 26.370 26.640 26.613 USD 4,365 22.87
2024-12-30 BUY 818 22.470 22.520 22.515 USD 18,417 22.70
2024-12-06 BUY 652 24.100 24.330 24.307 USD 15,848 22.55
2024-12-05 BUY 163 23.860 24.430 24.373 USD 3,973 22.50
2024-12-04 BUY 815 24.110 24.920 24.839 USD 20,244 22.45
2024-11-29 BUY 815 24.580 24.870 24.841 USD 20,245 22.19
2024-11-27 BUY 652 24.540 24.560 24.558 USD 16,012 21.98
2024-11-26 BUY 163 23.700 24.100 24.060 USD 3,922 21.91
2024-11-25 SELL -35,361 24.240 24.430 24.411 USD -863,197 21.79 Loss of -92,513 on sale
2024-11-21 BUY 1,355 23.000 23.140 23.126 USD 31,336 21.64
2024-11-20 BUY 813 22.930 22.950 22.948 USD 18,657 21.57
2024-11-18 BUY 3,240 22.490 22.970 22.922 USD 74,267 21.43
2024-11-12 BUY 2,160 24.810 25.520 25.449 USD 54,970 21.20
2024-11-08 BUY 1,350 24.780 25.750 25.653 USD 34,632 20.94
2024-11-07 BUY 4,050 25.510 26.570 26.464 USD 107,179 20.59
2024-11-06 BUY 540 26.700 26.960 26.934 USD 14,544 20.08
2024-10-31 BUY 270 18.760 19.540 19.462 USD 5,255 19.24
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-03	SELL	-575	13.650	13.270	13.308	USD -7,652	17.49 Profit of 2,405 on sale
2025-12-02	BUY	230	13.340	12.860	12.908	USD 2,969	17.51
2025-11-25	SELL	-345	13.295	12.485	12.566	USD -4,335	17.62 Profit of 1,743 on sale
2025-11-24	SELL	-345	12.600	11.950	12.015	USD -4,145	17.64 Profit of 1,941 on sale
2025-11-17	SELL	-1,265	11.905	11.510	11.550	USD -14,610	17.80 Profit of 7,902 on sale
2025-11-12	SELL	-115	12.730	12.070	12.136	USD -1,396	17.89 Profit of 661 on sale
2025-11-06	SELL	-115	11.330	11.010	11.042	USD -1,270	18.01 Profit of 801 on sale
2025-11-05	SELL	-1,150	11.570	10.870	10.940	USD -12,581	18.04 Profit of 8,168 on sale
2025-11-04	SELL	-230	11.600	11.220	11.258	USD -2,589	18.08 Profit of 1,569 on sale
2025-11-03	SELL	-230	11.845	11.080	11.156	USD -2,566	18.11 Profit of 1,600 on sale
2025-10-28	BUY	345	15.560	15.850	15.821	USD 5,458	18.21
2025-10-24	SELL	-115	16.120	16.270	16.255	USD -1,869	18.23 Profit of 227 on sale
2025-10-15	BUY	690	14.230	14.910	14.842	USD 10,241	18.35
2025-10-02	BUY	115	13.970	14.730	14.654	USD 1,685	18.39
2025-09-30	BUY	230	14.330	14.420	14.411	USD 3,315	18.44
2025-09-11	BUY	460	15.470	15.730	15.704	USD 7,224	18.57
2025-08-21	SELL	-163	13.680	14.240	14.184	USD -2,312	18.60 Profit of 720 on sale
2025-07-31	BUY	489	13.140	14.070	13.977	USD 6,835	18.66
2025-06-30	SELL	-326	12.270	12.500	12.477	USD -4,068	19.45 Profit of 2,273 on sale
2025-06-25	SELL	-163	11.870	12.010	11.996	USD -1,955	19.60 Profit of 1,240 on sale
2025-06-20	SELL	-326	11.600	12.140	12.086	USD -3,940	19.77 Profit of 2,505 on sale
2025-05-23	BUY	163	12.300	12.500	12.480	USD 2,034	20.94
2025-05-19	SELL	-163	13.550	13.620	13.613	USD -2,219	21.21 Profit of 1,239 on sale
2025-05-15	SELL	-489	13.010	13.090	13.082	USD -6,397	21.35 Profit of 4,044 on sale
2025-05-12	SELL	-163	13.670	13.930	13.904	USD -2,266	21.57 Profit of 1,249 on sale
2025-05-09	SELL	-163	12.250	12.890	12.826	USD -2,091	21.65 Profit of 1,439 on sale
2025-04-30	SELL	-163	16.390	17.200	17.119	USD -2,790	22.14 Profit of 819 on sale
2025-04-24	SELL	-326	16.700	16.920	16.898	USD -5,509	22.35 Profit of 1,778 on sale
2025-04-17	SELL	-163	15.830	15.960	15.947	USD -2,599	22.70 Profit of 1,101 on sale
2025-04-15	SELL	-489	16.080	16.910	16.827	USD -8,228	22.85 Profit of 2,946 on sale
2025-04-14	SELL	-489	16.730	17.290	17.234	USD -8,427	22.92 Profit of 2,780 on sale
2025-04-09	SELL	-652	19.190	19.250	19.244	USD -12,547	23.09 Profit of 2,508 on sale
2025-04-07	SELL	-1,141	19.580	20.410	20.327	USD -23,193	23.19 Profit of 3,267 on sale
2025-04-04	SELL	-1,630	19.570	19.860	19.831	USD -32,325	23.23 Profit of 5,546 on sale
2025-03-31	BUY	163	21.990	22.270	22.242	USD 3,625	23.29
2025-03-19	SELL	-326	22.820	22.950	22.937	USD -7,477	23.39 Profit of 149 on sale
2025-03-14	SELL	-978	22.350	22.890	22.836	USD -22,334	23.42 Profit of 573 on sale
2025-03-13	SELL	-328	22.270	22.730	22.684	USD -7,440	23.44 Profit of 248 on sale
2025-03-12	SELL	-5,576	22.240	24.370	24.157	USD -134,699	23.46 Loss of -3,907 on sale
2025-03-07	SELL	-328	23.000	23.190	23.171	USD -7,600	23.47 Profit of 98 on sale
2025-03-06	SELL	-492	22.030	22.090	22.084	USD -10,865	23.49 Profit of 692 on sale
2025-03-03	SELL	-164	22.480	23.560	23.452	USD -3,846	23.56 Profit of 17 on sale
2025-02-28	SELL	-984	23.210	23.250	23.246	USD -22,874	23.56 Profit of 313 on sale
2025-02-26	SELL	-164	23.600	24.860	24.734	USD -4,056	23.57 Loss of -191 on sale
2025-02-25	SELL	-492	24.720	25.450	25.377	USD -12,485	23.55 Loss of -898 on sale
2025-02-18	BUY	820	23.320	24.200	24.112	USD 19,772	23.68
2025-02-13	BUY	164	24.260	24.340	24.332	USD 3,990	23.64
2025-02-12	BUY	164	24.080	25.500	25.358	USD 4,159	23.64
2025-02-11	BUY	492	25.680	25.950	25.923	USD 12,754	23.59
2025-02-06	BUY	1,476	26.020	26.980	26.884	USD 39,681	23.46
2025-01-27	BUY	164	26.370	26.640	26.613	USD 4,365	22.87
2024-12-30	BUY	818	22.470	22.520	22.515	USD 18,417	22.70
2024-12-06	BUY	652	24.100	24.330	24.307	USD 15,848	22.55
2024-12-05	BUY	163	23.860	24.430	24.373	USD 3,973	22.50
2024-12-04	BUY	815	24.110	24.920	24.839	USD 20,244	22.45
2024-11-29	BUY	815	24.580	24.870	24.841	USD 20,245	22.19
2024-11-27	BUY	652	24.540	24.560	24.558	USD 16,012	21.98
2024-11-26	BUY	163	23.700	24.100	24.060	USD 3,922	21.91
2024-11-25	SELL	-35,361	24.240	24.430	24.411	USD -863,197	21.79 Loss of -92,513 on sale
2024-11-21	BUY	1,355	23.000	23.140	23.126	USD 31,336	21.64
2024-11-20	BUY	813	22.930	22.950	22.948	USD 18,657	21.57
2024-11-18	BUY	3,240	22.490	22.970	22.922	USD 74,267	21.43
2024-11-12	BUY	2,160	24.810	25.520	25.449	USD 54,970	21.20
2024-11-08	BUY	1,350	24.780	25.750	25.653	USD 34,632	20.94
2024-11-07	BUY	4,050	25.510	26.570	26.464	USD 107,179	20.59
2024-11-06	BUY	540	26.700	26.960	26.934	USD 14,544	20.08
2024-10-31	BUY	270	18.760	19.540	19.462	USD 5,255	19.24

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of IART

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	200,860	0	342,324	58.7%
2025-09-18	245,523	0	426,036	57.6%
2025-09-17	219,298	0	308,535	71.1%
2025-09-16	189,736	0	339,123	55.9%
2025-09-15	311,405	0	512,195	60.8%
2025-09-12	205,909	0	320,823	64.2%
2025-09-11	350,439	0	718,800	48.8%
2025-09-10	247,943	0	396,708	62.5%
2025-09-09	260,941	0	485,210	53.8%
2025-09-08	306,988	528	453,325	67.7%
2025-09-05	346,937	0	460,014	75.4%
2025-09-04	398,359	0	759,826	52.4%
2025-09-03	485,867	0	778,196	62.4%
2025-09-02	231,976	0	373,414	62.1%
2025-08-29	417,210	981	707,670	59.0%
2025-08-28	323,733	0	583,378	55.5%
2025-08-27	557,498	807	1,292,647	43.1%
2025-08-26	315,944	0	528,778	59.7%
2025-08-25	317,205	0	482,389	65.8%
2025-08-22	382,724	0	717,891	53.3%
2025-08-21	178,737	0	284,394	62.8%
2025-08-20	341,582	31	691,272	49.4%
2025-08-19	368,719	0	685,728	53.8%
2025-08-18	371,715	0	701,232	53.0%
2025-08-15	327,206	0	620,445	52.7%
2025-08-14	241,966	0	473,349	51.1%
2025-08-13	265,549	526	710,399	37.4%
2025-08-12	269,644	0	810,623	33.3%
2025-08-11	306,600	0	800,147	38.3%
2025-08-08	362,062	300	898,715	40.3%
2025-08-07	382,300	0	998,598	38.3%
2025-08-06	441,392	53	927,921	47.6%
2025-08-05	491,034	0	872,429	56.3%
2025-08-04	313,621	66,725	657,282	47.7%
2025-08-01	645,719	40,049	960,271	67.2%
2025-07-31	937,686	0	1,264,837	74.1%
2025-07-30	268,419	0	456,370	58.8%
2025-07-29	234,719	0	447,928	52.4%
2025-07-28	285,598	0	597,581	47.8%
2025-07-25	215,394	110	504,276	42.7%
2025-07-24	244,699	0	492,635	49.7%
2025-07-23	221,784	0	517,973	42.8%
2025-07-22	184,579	787	359,377	51.4%
2025-07-21	203,160	0	367,500	55.3%
2025-07-18	187,790	0	327,248	57.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE